We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Montirelin stimulates the release of thyrotropin and prolactin. It is synthesized by the neurons in the paraventricular nucleus of the hypothalamus. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the anterior pituitary gland.
CAT No: 10-101-64
CAS No: 62305-91-3
Synonyms/Alias: CG 3703; CG-3703; CG3703; CNK 602A; CNK602A; CNK-602A; CNK 603; CNK603; CNK-603; NS-3; NS3; NS 3; PS 24; Montirelin; Montireline; Montirelinum; Montirelin; Montirelina; CCRIS 7571; CCRIS7571
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C17H24N6O4S |
M.W/Mr. | 408.48 |
Sequence | 6-Me-5-oxothiomorpholinyl-3-carbonyl-His-Pro-NH2 |
Labeling Target | Thyrotrophin releasing hormone (TRH) receptor |
Application | Montirelin is a potent, biologically stable TRH analog for brain receptor binding. |
Activity | Agonist |
Areas of Interest | Hormonal therapy |
Source# | Synthetic |
Solubility | −20°C |
InChI | InChI=1S/C17H24N6O4S/c1-9-15(25)22-12(7-28-9)16(26)21-11(5-10-6-19-8-20-10)17(27)23-4-2-3-13(23)14(18)24/h6,8-9,11-13H,2-5,7H2,1H3,(H2,18,24)(H,19,20)(H,21,26)(H,22,25)/t9?,11-,12?,13-/m0/s1 |
InChI Key | RSHMQGIMHQPMEB-VEEXIGFHSA-N |
Isomeric SMILES | CC1C(=O)NC(CS1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N |
BoilingPoint | 994.2±65.0 °C at 760 mmHg |
References | The histaminergic tuberomamillary nucleus (TMN) controls arousal and attention and the firing of TMN neurons is state-dependent, active during waking, silent during sleep. Thyrotropin-releasing hormone (TRH) promotes arousal and combats sleepiness associated with narcolepsy. Single-cell RT-PCR (scRT-PCR) demonstrated variable expression of the two known TRH receptors in the majority of TMN neurons. TRH increased the firing rate of most (ca 70%) TMN neurons. This excitation was abolished in the presence of the TRH receptor antagonist chlordiazepoxide (50 μM). In the presence of tetrodotoxin TRH depolarized TMN neurons without changing their input resistance. This effect reversed at the potential typical for nonselective cation channels. The potassium channel blockers barium and cesium did not influence the TRH-induced depolarization. TRH effects were antagonized by inhibitors of the Na+/Ca2+ exchanger, KB-R7943 and benzamil. The frequency of spontaneous inhibitory GABAergic postsynaptic potentials was either increased (TTX-insensitive) or decreased (TTX-sensitive GABA release sites) by TRH, indicating a heterogeneous modulation of GABAergic inputs by TRH. Montirelin (TRH analogue, 1 mg/kg ip) induced waking in wild type mice but not in histidine decarboxylase knockout mice lacking histamine. Inhibition of histamine synthesis by (S)-α-fluoromethylhistidine blocked the arousal effect of montirelin in WT mice. We conclude, that direct excitation of rodent TMN neurons by TRH is receptor-mediated and demands activation of nonselective cation channels as well as electrogenic Na+/Ca2+ exchange. Our findings indicate a key role of histamine in TRH-induced arousal. Parmentier, R., Kolbaev, S., Klyuch, B. P., Vandael, D., Lin, J. S., Selbach, O., ... & Sergeeva, O. A. (2009). Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone. Journal of Neuroscience, 29(14), 4471-4483. |
Melting Point | N/A |
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
2. Emu oil in combination with other active ingredients for treating skin imperfections
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com